This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Claudia Kirstenpfad: Innovator in Anti-HLA-G Antibodies
Introduction
Claudia Kirstenpfad is a notable inventor based in Penzberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of anti-HLA-G antibodies. With a total of 2 patents to her name, her work has the potential to impact various medical applications.
Latest Patents
Claudia's latest patents include "Anti-HLA-G antibodies and methods of use thereof" and "Anti-HLA-G antibodies and use thereof." Both inventions focus on the development and application of anti-HLA-G antibodies, showcasing her expertise in this specialized area of research.
Career Highlights
Throughout her career, Claudia has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research.
Collaborations
Claudia has collaborated with esteemed colleagues such as Jens Fischer and Meher Majety. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Claudia Kirstenpfad is a pioneering inventor whose work on anti-HLA-G antibodies is paving the way for advancements in medical science. Her contributions are invaluable, and her patents reflect her dedication to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile